Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2014
11/18/2014US8889696 Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof
11/18/2014US8889695 Quinazolinone compounds
11/18/2014US8889693 Fibrosis inhibitor
11/18/2014US8889692 Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses
11/18/2014US8889691 Indole compounds as an inhibitor of cellular necrosis
11/18/2014US8889690 TRPV1 antagonists including dihydroxy substituent and uses thereof
11/18/2014US8889689 Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
11/18/2014US8889688 Piperazines as antimalarial agents
11/18/2014US8889687 Deuterated pyrazinoisoquinoline compounds
11/18/2014US8889686 Method of decreasing the bitterness of a pharmaceutical dosage form containing zopiclone
11/18/2014US8889685 Method for treating a sleep disorder with eszopiclone maleate
11/18/2014US8889684 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
11/18/2014US8889683 Substituted quinoxalines as inhibitors of fatty acid binding protein
11/18/2014US8889682 Inhibitors of bruton'S tyrosine kinase
11/18/2014US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies
11/18/2014US8889678 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
11/18/2014US8889677 Substituted triazoles useful as mGlu5 receptor modulators
11/18/2014US8889676 3-ureidoisoquinolin-8-yl derivatives
11/18/2014US8889675 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/18/2014US8889674 Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
11/18/2014US8889673 Triazolopyridine JAK inhibitor compounds and methods
11/18/2014US8889672 Compounds, formulations, and methods of protein kinase C inhibition
11/18/2014US8889671 Compounds and methods for treating bacterial infections
11/18/2014US8889670 Heterocyclic compounds which modulate the CB2 receptor
11/18/2014US8889669 Cytotoxic benzodiazepine derivatives
11/18/2014US8889668 Oxadiazole diaryl compounds
11/18/2014US8889667 Therapeutic compounds and compositions
11/18/2014US8889666 Quinolyl pyrrolo pyrimidyl condensed-ring compound and salt thereof
11/18/2014US8889665 Chemical compounds
11/18/2014US8889664 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/18/2014US8889663 Formulation for oral transmucosal administration of lipid-lowering drugs
11/18/2014US8889662 Method to alter sex ratios in avian offspring
11/18/2014US8889661 Treatment of lupus nephritis using laquinimod
11/18/2014US8889660 Methods for treating obesity or an obesity related condition
11/18/2014US8889659 Pain relief compositions, manufacture and uses
11/18/2014US8889658 Phosphonate compounds
11/18/2014US8889656 Boron-containing small molecules
11/18/2014US8889655 Compositions and methods for preventing infectious diseases in females
11/18/2014US8889654 Food formulation comprising glycogen
11/18/2014US8889653 Grafting polymerization of guar and other polysaccharides by electron beams
11/18/2014US8889652 Pharmaceutical agent having long-lasting effect of treating arthritic disorders
11/18/2014US8889651 Trehalose derivatives, preparation method and uses thereof
11/18/2014US8889650 Antimelancholic medicine prepared with jujube camp materials
11/18/2014US8889649 Composition containing antisense oligonucleotide to micro RNA
11/18/2014US8889646 Nucleic acid modulators of glycoprotein VI
11/18/2014US8889642 Methods and compositions for RNAi-based cancer treatment
11/18/2014US8889638 Stimulus-triggered prodrugs
11/18/2014US8889637 Polymorphs of 2′-O-fucosyllactose and producing thereof
11/18/2014US8889636 Anti-microbial compositions
11/18/2014US8889635 Dendrimer conjugates
11/18/2014US8889627 Treatment of multiple sclerosis with combination of laquinimod and fingolimod
11/18/2014US8889626 Triple cross-linked collagen, method of manufacturing the same, and use thereof
11/18/2014US8889622 Methods of inhibiting seizure in a subject
11/18/2014US8889621 Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia
11/18/2014US8889615 Methods for promoting epithelialization and healing of chronic wounds
11/18/2014US8889595 Herbicides
11/18/2014US8889426 Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia
11/18/2014US8889419 Methods for enhanced virus-mediated DNA transfer using molecules with virus- and cell-binding domains
11/18/2014US8889398 Composition for inactivating an enveloped virus
11/18/2014US8889375 Hypoglycemic effect enhancer
11/18/2014US8889346 Propofol formulations with non-reactive container closures
11/18/2014US8889237 Excipient system and medical container for erythrocyte enriched liquid
11/18/2014US8889198 Method for suppressing and relieving itching and inflammation
11/18/2014US8889197 Plant pathogen inhibitor combinations and methods of use
11/18/2014US8889196 Dental composites comprising nanoparticles of amorphous calcium phosphate
11/18/2014US8889195 Compositions comprising calcium citrate malate and methods for making the same
11/18/2014US8889194 Smoking cessation with body weight maintenance and nutritional supplement
11/18/2014US8889193 Sustained delivery of therapeutic agents to an eye compartment
11/18/2014US8889192 Magnetic nanomedicine for inhibiting/treating human prostate cancer
11/18/2014US8889191 Sustained-release formulations of topiramate
11/18/2014US8889190 Extended-release topiramate capsules
11/18/2014US8889188 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses
11/18/2014US8889187 Once a day amoxicillin product comprising immediate and delayed release dosage forms
11/18/2014US8889186 Modified release compositions comprising tacrolimus
11/18/2014US8889185 Modified release compositions comprising tacrolimus
11/18/2014US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/18/2014US8889180 Coated drug delivery formulations
11/18/2014US8889176 Method of managing or treating pain
11/18/2014US8889175 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
11/18/2014US8889174 Zero-order prolonged release coaxial implants
11/18/2014US8889173 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
11/18/2014US8889170 Implantable device having a coating with a triblock copolymer
11/18/2014US8889163 Facially amphiphilic polymers as anti-infective agents
11/18/2014US8889160 Ophthalmic compositions with biguanide and PEG-glycerol esters
11/18/2014US8889159 Compositions and methods for treating hepatitis C virus
11/18/2014US8889158 Intra-articularly supplementation method for treating joint diseases and injuries
11/18/2014US8889157 Composition for cardiovascular treatment
11/18/2014US8889155 Gel composition for treating mycosis
11/18/2014US8889154 Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/18/2014US8889126 Methods and compositions for treating neuropathies
11/18/2014US8889125 Treatment of Huntington's disease
11/18/2014US8889123 Compositions and soft tissue replacement methods
11/18/2014US8889119 Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy
11/18/2014US8889115 Ion binding polymers and uses thereof
11/18/2014US8889114 Composition and method for the inhibition of postoperative adhesions severity
11/18/2014US8889113 Compositions and kits for the removal of irritating compounds from bodily surfaces
11/18/2014US8889112 Ophthalmic formulations including selective alpha 1 antagonists
11/18/2014US8889109 Pharmaceutical dosage forms comprising valganciclovir hydrochloride
11/18/2014US8889101 Dendrimer based nanodevices for therapeutic and imaging purposes
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 7860